abrdn Life Sciences Investors (HQL) Insider Trading
Sector: N/A · Market Cap: $591M · 0 insider purchases in the last 7 days
No open market insider purchases at abrdn Life Sciences Investors in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track HQL on your watchlist.
Start for FreeAbout abrdn Life Sciences Investors Insider Trading
1 insider at abrdn Life Sciences Investors (HQL) has purchased stock in the past 90 days, totaling $10K across 1 transaction (527 shares).
The most recent purchase was by Director Mahai Chris LaVictoire on July 16, 2026 — a $10K buy of 527 shares at $19.92, bringing their total holdings to 527 shares.
This level of insider buying appears elevated compared to HQL's typical activity — there were 1 purchase in the prior nine months.
HQL is in the N/A sector within the N/A industry with a market cap of $591M.
Track HQL insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.
More Insider Trading in N/A
Eaton Vance Enhanced Equity Income Fund II
1 purchases (7d)
KYNKayne Anderson Energy Infrastructure Fund, Inc.
23 purchases (7d)
GRXGabelli Healthcare & WellnessRx Trust
29 purchases (7d)
ENHAEnhanced Group Inc.
5 purchases (7d)
ADMQADM ENDEAVORS, INC.
20 purchases (7d)
PDXPIMCO Dynamic Income Strategy Fund
7 purchases (7d)